(Q24246643)

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

Topical capsaicin in the management of HIV-associated peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

Randomized, placebo-controlled trial of Chinese herb therapy for HIV-1-infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

Use of a chinese herbal medicine for treatment of hiv-associated pathogen-negative diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

The effects of long-term herbal treatment for pediatric AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

HIV disease treatment in the era of HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. Italian Seroconversion Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

Interactions between herbal medicines and prescribed drugs: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

Liver enzyme elevations in patients treated with traditional Chinese medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

Impact of African herbal medicines on antiretroviral metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

How effective are complementary therapies for HIV and AIDs?--A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

Impact of HAART on the clinical management of AIDS-related cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

Antiretroviral therapy: state of the HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

Recent advances: complementary medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

Intention-to-treat approach to data from randomized controlled trials: a sensitivity analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

A phase I trial of andrographolide in HIV positive patients and normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

7 January 2021

Efficacy and safety of Buxus sempervirens L. preparations (SPV(30)) in HIV-infected asymptomatic patients: a multicentre, randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

7 January 2021

Treatment of HIV-related hairy leukoplakia with podophyllum resin 25% solution

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

7 January 2021

Gingival mass lesions in a patient with HIV infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

7 January 2021

Effects of qian-kun-nin, a Chinese herbal medicine formulation, on HIV positive subjects: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

7 January 2021

Assessment of effectiveness of traditional herbal medicine in managing HIV/AIDS patients in South Africa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003937.PUB2

7 January 2021